Established in 2012, this Manufacturer is a CTD dossier owner and manufacturer and GMP manufacturer with products sold in over 39 countries across four continents. With multiple WHO-GMP and other regulatory approvals (e.g., Ghana FDA, Philippines FDA, Kenya PBB, Tanzania TFDA, Nigeria NAFDAC), it operates several finished dosage and R&D production lines (tablets, capsules, injectables, liquids, softgels, effervescent, suppositories). As a CTD dossier owner and manufacturer, it supports regulatory filings worldwide. Headquartered in India and employing a global workforce, it serves diverse markets as a CTD dossier owner and manufacturer and GMP manufacturer.

This pharmaceutical company is a leading manufacturer known for its commitment to research and development (R&D) and innovative products. They specialize in a wide range of therapeutic areas, including gastroenterology, cardiovascular health, diabetes, oncology, pain management, and nephrology. Their product portfolio encompasses various dosage forms such as finished formulations, DC granules and pellets, APIs, and intermediates. The company holds multiple GMP certifications (EU GMP, WHO GMP, ISO) and boasts a global presence in over 50 nations across the EU, North America, and other regions. They are dedicated to producing high-quality, affordable medications accessible to patients worldwide.

This multi-faceted pharmaceutical company operates across various regions, including North America and the EU. Their product portfolio encompasses prescription medications, over-the-counter drugs, medical devices, and supplements, highlighting their expertise in diverse therapeutic areas such as oncology, cardiology, neurology, and infectious diseases. Their manufacturing facilities adhere to stringent GMP standards and hold relevant certifications. They possess several patents for key products, showcasing their commitment to innovation and research & development.